Tim Schoen
$1B
Volume$760M
Sold$322M
Financed8
Closed3M sf
AreaTim Schoen is an investor specializing in office assets with a transaction volume of $1B. Recent deals include BioMed Realty's acquisition of office properties for $160M and a $322M loan from KKR Real Estate and AllianceBernstein.
Focus
Member since October 2024
Deals
Transaction Type
Asset Type
State
Sort By
Eric D. Schlager Of The Bulfinch Cos Acquires Office Building From Tim Schoen For $15.1M In Cambridge
$232/SF
210 Broadway, Cambridge, MA
Russ Tedrake Of Walden Robotics Leases 50,000 Square Feet At BioMed Realty's 20 Sidney Street
20 Sidney Street, Cambridge, MA
Lenders KKR Real Estate And AllianceBernstein Finance Acquisition Of BioMed Realty For $322M
1000 Washington Street, Saint Maries, MA
TransMedics Group Signs 16-Year Lease At BioMed Realty's Assembly Innovation Park In Somerville
188 Assembly Park Drive, Somerville, MA
Tim Schoen Of BioMed Realty Acquires Pfizer's Biotech Campus In San Diego For $255M
$404/SF
10777 Science Center Drive, San Diego, CA
Alexandria Real Estate Sells Life Sciences Properties To BioMed Realty For $250 Million In Cambridge
$150/SF
215 First Street, Cambridge, MA
BioMed Realty Acquires Industrial Property On Eccles Avenue In South San Francisco For $80M
513 Eccles Avenue, South San Francisco, California 94080, United States, South San Francisco, CA
BioMed Realty Acquires Office Properties In Belmont & Redwood City For $160M
$800/SF
301-401 Island Parkway, Belmont, CA, USA, Belmont, CA